PRIME MEDICINE INC (PRME) Stock Balance Sheet
USA - NASDAQ:PRME - US74168J1016 - Common Stock
5.45 USD
-0.35 (-6.03%)
5.46 USD
+0.01 (+0.18%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 53.80M | 182.48M | 41.57M | 187.60M | 185.40M | |||
| Marketable Securities | 47.95M | 7.97M | 80.09M | 106.30M | 84.20M | |||
| Receivables | 120.00K | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 19.42M | 21.44M | 21.31M | 2.70M | 1.00M | |||
| Total Current Assets | 121.29M | 211.89M | 142.98M | 296.60M | 270.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 144.03M | 71.56M | 36.60M | 48.60M | 15.70M | |||
| Other Non-Current Assets | 13.69M | 14.06M | 14.28M | 15.10M | 15.60M | |||
| Total Non-Current Assets | 157.72M | 85.62M | 50.88M | 63.70M | 31.30M | |||
| TOTAL ASSETS | 279.01M | 297.51M | 193.85M | 360.30M | 301.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 14.64M | 14.53M | 33.32M | 20.40M | 43.50M | |||
| Accounts Payable | 6.38M | 11.35M | 19.54M | 4.30M | 1.40M | |||
| Other Current Liabilities | 13.09M | 12.08M | 3.57M | 2.00M | 13.00M | |||
| Total Current Liabilities | 34.11M | 37.96M | 56.42M | 26.70M | 58.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 0.00 | 300.00K | 1.20M | |||
| Other Non-Current Liabilities | 184.04M | 106.40M | 4.36M | 17.10M | 3.10M | |||
| Total Non-Current Liabilities | 184.04M | 106.40M | 4.36M | 17.30M | 4.30M | |||
| TOTAL LIABILITIES | 218.15M | 144.36M | 60.78M | 44.00M | 62.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -791.69M | -687.21M | -491.33M | -293.20M | -171.40M | |||
| Additional Paid In Capital | 852.56M | 840.36M | 624.41M | 609.80M | 15.20M | |||
| Common Shares | 2.00K | 2.00K | 2.00K | 0.00 | 395.80M | |||
| Shares Outstanding | 134.49M | 131.16M | 97.38M | 97.20M | 95.70M | |||
| Tangible Book Value per Share | 0.45 | 1.17 | 1.37 | 3.25 | -1.63 | |||
| Total Shareholders' Equity | 60.86M | 153.15M | 133.07M | 316.30M | 239.60M | |||
| TOTAL LIABILITIES AND EQUITY | 279.01M | 297.51M | 193.85M | 360.30M | 301.90M | |||
| Statistics | ||||||||
| Current Ratio | 3.56 | 5.58 | 2.53 | 11.11 | 4.67 | |||
| Return On Assets (ROA) | -71.42% | -65.84% | -102.21% | -39.41% | -60.99% | |||
| Return On Equity (ROE) | -327.43% | -127.90% | -148.89% | -44.90% | -76.84% | |||
All data in USD , ROIC based on taxRate of 0.21